4'-Methoxy-α-Pyrrolidinopentiophenone: Difference between revisions
en>Edgar181 Edgar181 moved page 4'-Methoxy-α-Pyrrolidinopentiophenone to 4'-Methoxy-α-pyrrolidinopentiophenone: WP:MOSCHEM decap. except for first word after the prefix |
m 1 revision imported |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''4'-Methoxy-α-Pyrrolidinopentiophenone''' ('''MOPPP''') is a [[designer drug]] that belongs to the [[cathinone]] class. It is a synthetic stimulant of the [[amphetamine]] class. MOPPP is a higher homologue of [[4'-Methyl-α-pyrrolidinopentiophenone]] ('''MPPP'''), and is often used in the research of central nervous system disorders. | |||
{{ | |||
==Chemistry== | |||
4'-Methoxy-α-Pyrrolidinopentiophenone is a synthetic cathinone. Cathinones are a sub-category of [[amphetamine]]s, which are organic compounds with a phenethylamine core. The chemical structure of MOPPP includes a phenyl ring bound to an amino (NH2) group through an ethyl chain with a ketone group at the beta carbon. It also has an additional methoxy group at the 4' position of the phenyl ring. | |||
==Pharmacology== | |||
The pharmacological properties of 4'-Methoxy-α-Pyrrolidinopentiophenone are not well-studied. However, it is known that synthetic cathinones are generally [[monoamine]] releasers. They are believed to enhance the release of monoamines like [[dopamine]], [[norepinephrine]], and [[serotonin]] in the brain, leading to stimulant effects. | |||
==Legality== | |||
The legality of 4'-Methoxy-α-Pyrrolidinopentiophenone varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. In the United States, it is a Schedule I controlled substance under the [[Controlled Substances Act]]. | |||
==See Also== | |||
* [[4'-Methyl-α-pyrrolidinopentiophenone]] | |||
* [[Cathinone]] | |||
* [[Designer drug]] | |||
* [[Amphetamine]] | |||
[[Category:Designer drugs]] | |||
[[Category:Cathinones]] | |||
[[Category:Stimulants]] | |||
{{pharm-stub}} | |||
{{drug-stub}} | |||
Latest revision as of 20:28, 12 March 2025
4'-Methoxy-α-Pyrrolidinopentiophenone (MOPPP) is a designer drug that belongs to the cathinone class. It is a synthetic stimulant of the amphetamine class. MOPPP is a higher homologue of 4'-Methyl-α-pyrrolidinopentiophenone (MPPP), and is often used in the research of central nervous system disorders.
Chemistry[edit]
4'-Methoxy-α-Pyrrolidinopentiophenone is a synthetic cathinone. Cathinones are a sub-category of amphetamines, which are organic compounds with a phenethylamine core. The chemical structure of MOPPP includes a phenyl ring bound to an amino (NH2) group through an ethyl chain with a ketone group at the beta carbon. It also has an additional methoxy group at the 4' position of the phenyl ring.
Pharmacology[edit]
The pharmacological properties of 4'-Methoxy-α-Pyrrolidinopentiophenone are not well-studied. However, it is known that synthetic cathinones are generally monoamine releasers. They are believed to enhance the release of monoamines like dopamine, norepinephrine, and serotonin in the brain, leading to stimulant effects.
Legality[edit]
The legality of 4'-Methoxy-α-Pyrrolidinopentiophenone varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act.
See Also[edit]
